IL17A and stroke disorder: More importantly, we found that the increased IL-17A-expressing γδ T cells, as well as the increased IL-17A protein levels in both lung tissue and plasma after stroke, were significantly reduced in the αCD147-treated group compared with the isotype-treated group.